William Blair downgraded Quintiles IMS Holdings Inc (NYSE:Q) to Market Perform in a statement released earlier today.
- Updated: December 1, 2016
Having a price of $76.83, Quintiles IMS Holdings Inc (NYSE:Q) traded -4.99% lower on the day. With the last stock close price up -0.77% from the two hundred day average, compared with the S&P 500 Index which has decreased -0.03% over the same time. The company has recorded a 50-day moving average of $75.98 and a 200-day moving average of $73.57. Trade Volume was up over the average, with 5,998,122 shares of Q changing hands over the typical 1,541,710
William Blair has downgraded Quintiles IMS Holdings Inc (NYSE:Q) to Market Perform in a report released on Thursday December 01, 2016.
Previously on 11/30/2016, Barclays Capital reported about Quintiles IMS Holdings Inc (NYSE:Q) increased the target price from $0.00 to $90.00 that suggested an upside of 0.15%.
With a total market value of $0, Quintiles IMS Holdings Inc has PE ratio of 22.45 with a 52 week low of $55.01 and a 52 week high of $81.45 .
Also covering Quintiles IMS Holdings Inc's price target, a total of 15 equity analysts have released a ratings update on Q. The one year target is $76.50 with eight analysts rating the company a strong buy, nine firms rating the stock a buy, 2 firms rating the stock a hold, 0 brokerages rating the stock a underperform, and finally 0 brokerages rating the stock a sell.
General Information About Quintiles IMS Holdings Inc (NYSE:Q)
Quintiles IMS Holdings Inc, formerly Quintiles Transnational Holdings Inc., is a provider of biopharmaceutical development services and commercial outsourcing services. It is engaged in the development and commercialization of pharmaceutical therapies. Its segments include Product Development and Integrated Healthcare Services. Its Product Development segment is a contract research organization and is focused on Phase II-IV clinical trials and associated laboratory and analytical activities. The Integrated Healthcare Services segment includes commercial pharmaceutical sales and service organizations, and provides services, including commercial services, such as contract pharmaceutical sales forces, and healthcare business services for the healthcare sector, such as phase research, market access and consulting, health information analytics and technology consulting, and other healthcare solutions.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.